Back to Journals » Cancer Management and Research » Volume 11

Review

Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer

       
Total article views   HTML views PDF downloads Totals
14,656 Dovepress* 8,133+ 1,225 9,358
PubMed Central* 6,523 902 7,425
Totals 14,656 2,127 16,783
*Since 16 August 2019

View citations on PubMed Central and Google Scholar